4.3 Article

Low-dose fentanyl does not alter muscle sympathetic nerve activity, blood pressure, or tolerance during progressive central hypovolemia

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpregu.00217.2021

Keywords

cerebral tissue oxygenation; opioids; respiration; sympathoexcitatory

Categories

Funding

  1. Department of Defense United States Army [W81XWH1820012]
  2. National Institutes of Health (NIH) [F32HL154559]
  3. NIH [F32HL154565]

Ask authors/readers for more resources

The study found that administration of an analgesic dose of fentanyl does not alter muscle sympathetic nerve activity or blood pressure during profound central hypovolemia in conscious humans, nor does it impair tolerance to simulated hemorrhage.
Hemorrhage is a leading cause of battlefield and civilian trauma deaths. Several pain medications, including fentanyl, are recommended for use in the prehospital (i.e., field setting) for a hemorrhaging solider. However, it is unknown whether fentanyl impairs arterial blood pressure (BP) regulation, which would compromise hemorrhagic tolerance. Thus, the purpose of this study was to test the hypothesis that an analgesic dose of fentanyl impairs hemorrhagic tolerance in conscious humans. Twenty-eight volunteers (13 females) participated in this double-blinded, randomized, placebo-controlled trial. We conducted a presyncopal limited progressive lower body negative pressure test (LBNP; a validated model to simulate hemorrhage) following intravenous administration of fentanyl (75 mg) or placebo (saline). We quantified tolerance as a cumulative stress index (mmHg center dot min), which was compared between trials using a paired, two-tailed t test. We also compared muscle sympathetic nerve activity (MSNA; microneurography) and beat-to-beat BP (photoplethysmography) during the LBNP test using a mixed effects model [time (LBNP stage) x trial]. LBNP tolerance was not different between trials (fentanyl: 647 +/- 386 vs. placebo: 676 +/- 295 mmHg center dot min, P = 0.61, Cohen's d = 0.08). Increases in MSNA burst frequency (time: P < 0.01, trial: P = 0.29, interaction: P = 0.94) and reductions in mean BP (time: P < 0.01, trial: P = 0.50, interaction: P = 0.16) during LBNP were not different between trials. These data, the first to be obtained in conscious humans, demonstrate that administration of an analgesic dose of fentanyl does not alter MSNA or BP during profound central hypovolemia, nor does it impair tolerance to this simulated hemorrhagic insult.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available